Please Wait
Applying Filters...
menu
    • menu
    Quotient Sciences-PSE
    News
    Quotient Sciences Extends Mfg Partnership For Ultra-Rare Disease

    27 Feb 2026

    // PRESS RELEASE

    First-in-Human Is Not Just About Safety

    09 Feb 2026

    // PRESS RELEASE

    VP Marlene Leuenberger on CPHI Online A Day in the Life

    27 Jan 2026

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Quotient rm 250x250

    Contact Supplier

    Website

    BIO-Europe Spring

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/O2qjELq5xJc
    Menu

    Quotient Sciences

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Quotient Sciences

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Inspected

    RoW
    DCAT Week
    Attending

    Quotient Sciences

    Inspection : Brazilian Health Regulatory Agency (ANVISA)

    About the Company : With trusted scientific insight brought to every program and more than 35 years of experience ensuri...

    With trusted scientific insight brought to every program and more than 35 years of experience ensuring quality and control throughout development, Quotient Sciences is a drug development and manufacturing accelerator helping clients bring molecules to cures faster. The company provides integrated services spanning drug product development from early phase through late stage and commercial supply, alongside clinical pharmacology capabilities supporting first-in-human (FIH), SAD and MAD studies. Its Translational Pharmaceutics® platform integrates manufacturing with clinical testing to accelerate development timelines and improve outcomes.

    Country : United Kingdom

    Quotient

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    Inspected

    RoW
    DCAT Week
    Attending

    Quotient Sciences

    Inspection : Ministry of Industry and Trade of the Russian Federation

    About the Company : With trusted scientific insight brought to every program and more than 35 years of experience ensuri...

    With trusted scientific insight brought to every program and more than 35 years of experience ensuring quality and control throughout development, Quotient Sciences is a drug development and manufacturing accelerator helping clients bring molecules to cures faster. The company provides integrated services spanning drug product development from early phase through late stage and commercial supply, alongside clinical pharmacology capabilities supporting first-in-human (FIH), SAD and MAD studies. Its Translational Pharmaceutics® platform integrates manufacturing with clinical testing to accelerate development timelines and improve outcomes.

    Country : United Kingdom

    Quotient

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    Inspected

    RoW
    DCAT Week
    Attending

    Quotient Sciences

    Inspection : Japanese Pharmaceuticals & Medical Devices Agency (PMDA)

    About the Company : With trusted scientific insight brought to every program and more than 35 years of experience ensuri...

    With trusted scientific insight brought to every program and more than 35 years of experience ensuring quality and control throughout development, Quotient Sciences is a drug development and manufacturing accelerator helping clients bring molecules to cures faster. The company provides integrated services spanning drug product development from early phase through late stage and commercial supply, alongside clinical pharmacology capabilities supporting first-in-human (FIH), SAD and MAD studies. Its Translational Pharmaceutics® platform integrates manufacturing with clinical testing to accelerate development timelines and improve outcomes.

    Country : United Kingdom

    Quotient

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    Inspected

    RoW
    DCAT Week
    Attending

    Quotient Sciences

    Inspection : Chinese National Medical Products Administration (NMPA)

    About the Company : With trusted scientific insight brought to every program and more than 35 years of experience ensuri...

    With trusted scientific insight brought to every program and more than 35 years of experience ensuring quality and control throughout development, Quotient Sciences is a drug development and manufacturing accelerator helping clients bring molecules to cures faster. The company provides integrated services spanning drug product development from early phase through late stage and commercial supply, alongside clinical pharmacology capabilities supporting first-in-human (FIH), SAD and MAD studies. Its Translational Pharmaceutics® platform integrates manufacturing with clinical testing to accelerate development timelines and improve outcomes.

    Country : United Kingdom

    Quotient

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.